HCN Subunit-Specific and cAMP-Modulated Effects of Anesthetics on Neuronal Pacemaker Currents
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
1056 Objectives: Ascorbate is a water-soluble antioxidant vitamin. Emerging clinical studies have used ascorbate as a cancer chemotherapeutic agent, and to ameliorate chemotherapy-induced side effects in several types of cancers, including glioblastoma, head and neck squamous cell carcinoma (HNSCC), prostate cancer (PCa) and breast cancer. Although hundreds of patients receive ascorbate treatments for advanced cancers, only a few have achieved an anticancer response. Proactively identifying those who will respond to a given treatment will help clinicians provide the right therapeutic alternatives. However, it is unclear how ascorbate works in reactive oxygen species (ROS) environments in tumor cells. We recently reported the design, synthesis, automated radiochemical production of [18F]KS1, a fluroethoxy-ascorbate derivative and its initial in vitro and in vivo PET imaging in PCa tumor-bearing mice.1 Herein, we describe the ROS-tracking properties of KS1 at tracer levels and suppression of tumor growth in cancer cells at pharmacologic doses. We also report the PET imaging properties of [18F]KS1 in a murine model of HNSCC. Methods: We used DCFDA ROS detection assay kit using the antibody, ab113851 to demonstrate the ROS generation property of KS1. Both SCC-61, a radiation-sensitive HNSCC cell line and PC3, a PCa cell line were incubated with KS1 and ascorbate at 10 µM and 100 µM for 7 h. The same assay was repeated with 0.1 mM and 2 mM of KS1 and ascorbate (n=6). The kit uses tert-butyl hydrogen peroxide, a common ROS inducer as a positive control, and N-acetyl cysteine, a common ROS suppressor as a negative control. ROS intensity was analyzed on a Tecan fluorescent reader and the data was expressed as mean fluorescent values ± SD (n=6). MicroPET imaging and biodistribution studies were performed in SCC-61 and rSCC-61 (radiation-sensitive and radiation-resistant HNSCC respectively) tumor-bearing mice (n=5) for 20 min after 45 min [18F]KS1 post-injection. Results: KS1 at 10 µM and 100 µM did not generate any ROS in both SCC-61 and PC3 cell lines. There was no significant change in the intensity between KS1 and ascorbate KS1 intensity at 2 mM increased significantly compared to the intensity at 100 µM. The uptake was close to the positive control TBHP. More importantly, the increased uptake was lowered (~3-fold) with SOD addition. Ascorbate intensity also increased, but not as KS1. With microPET, we observed high [18F]KS1 uptake in SCC-61 vs. rSCC-61 tumors. From the basic region of interest analysis on mPET scans, ROS-expressing SCC-61 tumors showed ~1.2-fold higher tumor uptake than rSCC-61 tumors, demonstrating high target selectivity. Biodistribution results show excellent tumor to muscle ratio in SCC-61 (10.93) and rSCC-61 tumors (4.11), with ~2.5-fold enrichment in SCC-61 tumors. These biodistribution results were consistent with in vitro cell uptake and microPET/CT imaging results. Additionally, [18F]KS1’s higher tumor uptake in SCC-61 tumors establishes its validity to distinguish high from low ROS tumor tissue (see supporting info). More importantly, the radioactivity profile is similar to the distribution kinetics in normal mice at 30 min post-injection. Conclusions: KS1 do not generate ROS in tumor cells at tracer level concentrations (≤100 uM) and tumor-killing properties by inducing ROS generation at pharmacologic doses (≥1.0 mM), and behave like ascorbate. [18F]KS1 exhibited high tumor uptake in vivo, with superior specificity and selectivity, and favorable pharmacokinetics in several tumor-bearing mice. This would be the first [18F]-based PET tracer, based on a natural vitamin to image ROS in tumor cells in vivo, with a clear mechanistic profile. Based on our promising data, we hypothesize that ascorbate-based PET ligand strategy will expand the ascorbate scaffold for potential imaging agent(s) to image ROS in vivo. 1Solingapuram et al; EJNMMI 2019,9 (1), 43.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thalamocortical oscillations in the sleeping and aroused brain
Steriade, M., McCormick, D. A., & Sejnowski, T. J. (1993) · Science · doi:10.1126/science.8235588 · Cited by 3,564 · cited 2×
“, thalamocortical rhythms) (Steriade et al., 1993; McCormick and Bal, 1997; Alkire et al., 2000; Antkowiak, 2002; Harrison, 2002; Campagna et al., 2003), suggest that Ih modulation may contribute to clinical actions of these important drugs.”
BackgroundSleep and arousal: thalamocortical mechanisms
McCormick, D. A., & Bal, T. (1997) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.20.1.185 · Cited by 1,267
Inhalational anesthetics activate two-pore-domain background K+ channels
Patel, A. J., Honoré, E., Lesage, F., Fink, M., Romey, G., & Lazdunski, M. (1999) · Nature Neuroscience · doi:10.1038/8084 · Cited by 655
Santoro, B., Chen, S., Lüthi, A., Pavlidis, P., Shumyatsky, G. P., Tibbs, G. R., & Siegelbaum, S. A. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-14-05264.2000 · Cited by 600 · cited 3×
“1C), with an apparent predominance of the HCN1 subunit (Moosmang et al., 1999; Monteggia et al., 2000; Santoro et al., 2000).”
BackgroundMethodJurd, R., Arrasa, M., Lambert, S., Drexler, B., Siegwart, R., Crestani, F., Zaugg, M., Vogt, K. E., Ledermann, B., Antkowiak, B., et al. (2003) · The FASEB Journal · doi:10.1096/fj.02-0611fje · Cited by 558
TREK-1, a K+ channel involved in neuroprotection and general anesthesia
Heurteaux, C., Guy, N., Laigle, C., Blondeau, N., Duprat, F., Mazzuca, M., Lang‐Lazdunski, L., Widmann, C., Zanzouri, M., Romey, G., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600234 · Cited by 534
Alkire, M. T., Haier, R. J., & Fallon, J. H. (2000) · Consciousness and Cognition · doi:10.1006/ccog.1999.0423 · Cited by 391
General anaesthetic actions on ligand-gated ion channels
Krasowski, M. D., & Harrison, N. L. (1999) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180050371 · Cited by 384
Sedation and Anesthesia Mediated by Distinct GABA A Receptor Isoforms
Reynolds, D. S., Rosahl, T. W., Cirone, J., O'Meara, G. F., Haythornthwaite, A., Newman, R. J., Myers, J., Sur, C., Howell, O., Rutter, A. R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-24-08608.2003 · Cited by 318 · cited 1×
“, etomidate or propofol) (Jurd et al., 2003; Reynolds et al., 2003) (for review, see Rudolph and Mohler, 2004).”
BackgroundVolatile general anaesthetics activate a novel neuronal K+ current
Franks, N. P., & Lieb, W. R. (1988) · Nature · doi:10.1038/333662a0 · Cited by 199
Cited by
General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal
Franks, N. P. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2372 · Cited by 1,295
Hyperpolarization-Activated Cation Channels: From Genes to Function
Biel, M., Wahl-Schott, C., Michalakis, S., & Zong, X. (2009) · Physiological Reviews · doi:10.1152/physrev.00029.2008 · Cited by 1,003
Emerging molecular mechanisms of general anesthetic action
Hemmings, H. C., Akabas, M. H., Goldstein, P. A., Trudell, J. R., Orser, B. A., & Harrison, N. L. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.08.006 · Cited by 552
Molecular targets underlying general anaesthesia
Franks, N. P. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706441 · Cited by 380
HCN1 Channel Subunits Are a Molecular Substrate for Hypnotic Actions of Ketamine
Chen, X., Shu, S., & Bayliss, D. A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3481-08.2009 · Cited by 277
Self-citation
Metadata
- Authors
- Chen, X.
- Venue
- Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2005-06-15
- Volume
- 25
- Issue
- 24
- Pages
- 5803-5814
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W1974119455
- Cited by
- 81
- References
- 10
- FWCI
- 2.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: HCN Subunit-Specific and cAMP-Modulated Effects of Anesthetics on Neuronal Pacemaker Currents. https://app.cochat.ai/papers/10.1523/jneurosci.1153-05.2005
- The paper
- Chen, X. (2005). HCN Subunit-Specific and cAMP-Modulated Effects of Anesthetics on Neuronal Pacemaker Currents. Journal of Neuroscience. https://doi.org/10.1523/jneurosci.1153-05.2005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.